Aditxt, Inc. (ADTX)
OTCMKTS · Delayed Price · Currency is USD
0.0068
-0.0004 (-5.56%)
At close: Sep 3, 2026
Aditxt Revenue
Aditxt had revenue of $12.16K in the quarter ending March 31, 2026, with 1,094.40% growth. This brings the company's revenue in the last twelve months to $14.34K, down -74.09% year-over-year. In the year 2025, Aditxt had annual revenue of $3.20K, down -97.62%.
Revenue (ttm)
14.34K
Revenue Growth
-74.09%
P/S Ratio
0.39
Revenue / Employee
551.38
Employees
26
Market Cap
5.55K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.20K | -130.79K | -97.62% |
| Dec 31, 2024 | 133.99K | -511.19K | -79.23% |
| Dec 31, 2023 | 645.18K | -288.54K | -30.90% |
| Dec 31, 2022 | 933.72K | 828.68K | 788.96% |
| Dec 31, 2021 | 105.03K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aridis Pharmaceuticals | 22.36M |
| MultiCell Technologies | 805.24K |
| Theralink Technologies | 635.45K |
| Bioasis Technologies | 199.01K |
| Therapeutic Solutions International | 85.32K |
| MetaStat | 23.30K |
Aditxt News
- 2 months ago - Why Is Penny Stock Aditxt (ADTX) Up Today? - TipRanks
- 2 months ago - Aditxt signs agreement valuing Ignite Proteomics at $150M - TheFly
- 2 months ago - Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million - Business Wire
- 2 months ago - Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection - Business Wire
- 3 months ago - Aditxt appoints Busch as interim CEO - TheFly
- 3 months ago - Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders - Business Wire
- 3 months ago - Aditxt announces 1-for-27 reverse stock split - TheFly
- 3 months ago - Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 - Business Wire